Viridian Therapeutics, Inc. (LON:0K1R)
London · Delayed Price · Currency is GBP · Price in USD 28.63
-1.62 (-5.36%)
Feb 12, 2026, 4:19 PM GMT
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of 2.1 billion as of February 12, 2026. Its market cap has increased by 71.91% in one year.
Market Cap
2.10B
Enterprise Value
1.90B
Revenue
52.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.63
Market Cap Chart
Since February 14, 2017, Viridian Therapeutics's market cap has increased from 138.06M to 2.10B, an increase of 1,423.54%. That is a compound annual growth rate of 35.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.10B | -4.68% |
| Dec 31, 2025 | 2.21B | 81.94% |
| Dec 31, 2024 | 1.21B | 34.90% |
| Dec 29, 2023 | 899.17M | -7.85% |
| Dec 30, 2022 | 975.73M | 207.65% |
| Dec 31, 2021 | 317.16M | 573.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 2.04B |
| Oxford Nanopore Technologies | 1.29B |
| Oxford Biomedica | 986.00M |
| PureTech Health | 311.77M |
| Avacta Group | 260.26M |
| Scancell Holdings | 129.72M |
| Bioventix | 91.44M |
| 4basebio | 91.32M |